This Open Enrollment Season, Look Out for Health Insurance That Seems Too Good to Be True

Complaints about misleading health insurance marketing are soaring. State insurance commissioners are taking notice. They’ve created a shared internal database to monitor questionable business practices, and, in the future, they hope to provide a public-facing resource for consumers. In the meantime, consumers should shop wisely as open enrollment season begins.

$38,398 for a Single Shot of a Very Old Cancer Drug

Lupron, a drug patented half a century ago, treats advanced prostate cancer. It’s sold to physicians for $260 in the U.K. and administered at no charge. Why are U.S. hospitals — which may pay nearly as little for the drug — charging so much more to administer it?

Drivers in Decline: A Shortage of Volunteers Complicates Access to Care in Rural America

Public transit is already insufficient in rural areas, leaving residents with few options as they travel greater distances to access health care. But older residents who depend on volunteer drivers to get them to appointments face another challenge: The number of those volunteers is declining.

Mental Health Crisis Teams Aren’t Just for Cities Anymore

In many cities, social workers and counselors are responding to mental health emergencies that used to be solely handled by police. That approach is spreading to rural areas even though mental health professionals are scarcer and travel distances are longer.

Hemp-Derived Delta-8 Skirts Marijuana Laws and Raises Health Concerns

A cannabis product called delta-8 was made legal when the 2018 Farm Bill legalized hemp. But unlike its cousin CBD, delta-8 has psychoactive properties. And the FDA warns it has “serious health risks.” The agency has received more than 100 reports of bad reactions among people who consumed it.

Buy and Bust: After Platinum Health Took Control of Noble Sites, All Hospital Workers Were Fired

Two Missouri towns are without operating hospitals after private equity-backed Noble Health left both facilities mired in debt, lawsuits, and federal investigations. The hospitals’ new operator, Platinum Health, agreed to buy them in April for $2 and laid off the last employees in early September.

Newborns Get Routine Heel Blood Tests, but Should States Keep Those Samples?

Shortly after birth, babies are pricked in the heel so their blood can be tested for life-threatening conditions. States generally save leftover blood from those samples, and parents and privacy experts are concerned that information could be used without consent years later.